SRSF10 inhibition prevents HCC growth and metastasis and enhances the anti-PD-L1- mediated tumor suppression
Xiangyuan Luo(Tongji Hospital), Limin Xia(National Clinical Research Center for Digestive Diseases)
Cited by 0
Related Papers
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
|Journal of Experimental & Clinical Cancer Research|2021|216
SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis
|Cell Death and Disease|2019|122
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
|Experimental Hematology and Oncology|2021|101
Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP
|Theranostics|2020|60
MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
|Clinical and Molecular Hepatology|2025|10